Clinical trial
Study of Clonidine on Sleep Architecture in Children With Tourette's Syndrome…
NCT00152750 · University Health Network, Toronto, Other · Unknown status
Key facts
| NCT number | NCT00152750 |
|---|---|
| Title | Study of Clonidine on Sleep Architecture in Children With Tourette's Syndrome (TS) and Comorbid ADHD |
| Official title | Aggressive Behaviour in Children With Tourette's Syndrome (TS) and Comorbid Attention Deficit Hyperactivity Disorder (ADHD) |
| Lead sponsor | University Health Network, Toronto, Other |
| Collaborators | The Hospital for Sick Children |
| Status | Unknown status |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Tourette's Syndrome, Attention Deficit Hyperactivity Disorder |
| Intervention type | Drug |
| Interventions | APO-clonidine |
| Enrollment | 32 |
| Start date | Sep 1, 2006 |
| Completion | Oct 1, 2008 |
| First posted | Sep 9, 2005 |
| Last update posted | Feb 28, 2007 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: